125 related articles for article (PubMed ID: 9584266)
1. Niemann-Pick disease type C and defective peroxisomal beta-oxidation of branched-chain substrates.
Sequeira JS; Vellodi A; Vanier MT; Clayton PT
J Inherit Metab Dis; 1998 Apr; 21(2):149-54. PubMed ID: 9584266
[TBL] [Abstract][Full Text] [Related]
2. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.
Christensen E; Pedersen SA; Leth H; Jakobs C; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1997 Sep; 20(5):658-64. PubMed ID: 9323560
[TBL] [Abstract][Full Text] [Related]
3. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
4. Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.
Mandel H; Berant M; Aizin A; Gershony R; Hemmli S; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1992; 15(3):381-4. PubMed ID: 1405475
[No Abstract] [Full Text] [Related]
5. Ataxia associated with increased plasma concentrations of pristanic acid, phytanic acid and C27 bile acids but normal fibroblast branched-chain fatty acid oxidation.
Clayton PT; Johnson AW; Mills KA; Lynes GW; Wilson J; Casteels M; Mannaerts G
J Inherit Metab Dis; 1996; 19(6):761-8. PubMed ID: 8982949
[TBL] [Abstract][Full Text] [Related]
6. Bile acid analyses in "pseudo-Zellweger" syndrome; clues to the defect in peroxisomal beta-oxidation.
Clayton PT; Lake BD; Hjelm M; Stephenson JB; Besley GT; Wanders RJ; Schram AW; Tager JM; Schutgens RB; Lawson AM
J Inherit Metab Dis; 1988; 11 Suppl 2():165-8. PubMed ID: 3141700
[No Abstract] [Full Text] [Related]
7. Reduced cholesterol accumulation and improved deficient peroxisomal functions in a murine model of Niemann-Pick type C disease upon treatment with peroxisomal proliferators.
Schedin S; Pentchev P; Dallner G
Biochem Pharmacol; 1998 Nov; 56(9):1195-9. PubMed ID: 9802331
[TBL] [Abstract][Full Text] [Related]
8. X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters.
Wanders RJ; van Roermund CW; van Wijland MJ; Nijenhuis AA; Tromp A; Schutgens RB; Brouwer-Kelder EM; Schram AW; Tager JM; van den Bosch H
Clin Chim Acta; 1987 Jun; 165(2-3):321-9. PubMed ID: 3652454
[TBL] [Abstract][Full Text] [Related]
9. Identification of unusual 7-oxygenated bile acid sulfates in a patient with Niemann-Pick disease, type C.
Alvelius G; Hjalmarson O; Griffiths WJ; Björkhem I; Sjövall J
J Lipid Res; 2001 Oct; 42(10):1571-7. PubMed ID: 11590212
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency.
Van Veldhoven PP; Meyhi E; Squires RH; Fransen M; Fournier B; Brys V; Bennett MJ; Mannaerts GP
Eur J Clin Invest; 2001 Aug; 31(8):714-22. PubMed ID: 11473573
[TBL] [Abstract][Full Text] [Related]
11. CoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl-CoA beta-oxidation.
Vamecq J; Vallee L; Fontaine M; Lambert D; Poupaert J; Nuyts JP
FEBS Lett; 1993 May; 322(2):95-100. PubMed ID: 8482393
[TBL] [Abstract][Full Text] [Related]
12. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease.
Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM
Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873
[TBL] [Abstract][Full Text] [Related]
13. The role of the carnitine system in peroxisomal fatty acid oxidation.
Ramsay RR
Am J Med Sci; 1999 Jul; 318(1):28-35. PubMed ID: 10408758
[TBL] [Abstract][Full Text] [Related]
14. Evidence that multifunctional protein 2, and not multifunctional protein 1, is involved in the peroxisomal beta-oxidation of pristanic acid.
Dieuaide-Noubhani M; Asselberghs S; Mannaerts GP; Van Veldhoven PP
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):367-73. PubMed ID: 9230115
[TBL] [Abstract][Full Text] [Related]
15. Activation and peroxisomal beta-oxidation of fatty acids and bile acid intermediates in liver from Bombina orientalis and from the rat.
Casteels M; Schepers L; Parmentier G; Eyssen HJ; Mannaerts GP
Comp Biochem Physiol B; 1989; 92(1):129-32. PubMed ID: 2706931
[TBL] [Abstract][Full Text] [Related]
16. Peroxisomal beta-oxidation enzymes.
Hashimoto T
Neurochem Res; 1999 Apr; 24(4):551-63. PubMed ID: 10227687
[TBL] [Abstract][Full Text] [Related]
17. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
18. [The contribution of peroxisomes to lipid metabolism].
Kramar R
J Clin Chem Clin Biochem; 1986 Feb; 24(2):109-18. PubMed ID: 3711795
[TBL] [Abstract][Full Text] [Related]
19. Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders.
Wanders RJ; Denis S; van Berkel E; Wouters F; Wirtz KW; Seedorf U
J Inherit Metab Dis; 1998 Jun; 21(3):302-5. PubMed ID: 9686381
[No Abstract] [Full Text] [Related]
20. The role of peroxisomal fatty acyl-CoA beta-oxidation in bile acid biosynthesis.
Hayashi H; Miwa A
Arch Biochem Biophys; 1989 Nov; 274(2):582-9. PubMed ID: 2802630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
